Beijing Science Sun Pharmaceutical Co Ltd (300485) — Financial Flexibility Index
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥44.20 Million (operating CF CN¥28.68 Million minus capex CN¥15.52 Million) represents 0% of total liabilities (CN¥171.26 Million). Also explore Beijing Science Sun Pharmaceutical Co Lt equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Science Sun Pharmaceutical Co Ltd Financial Flexibility Index (2011–2024)
Historical Financial Flexibility Index trend for Beijing Science Sun Pharmaceutical Co Ltd across 14 annual periods. Check Beijing Science Sun Pharmaceutical Co Lt strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
Year-by-year free cash flow to debt coverage for Beijing Science Sun Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Beijing Science Sun Pharmaceutical Co Lt.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.42x | CN¥237.10 Million | CN¥135.97 Million | CN¥166.48 Million | ▲ +197.1% |
| 2023 | 0.48x | CN¥74.12 Million | CN¥21.21 Million | CN¥154.61 Million | ▼ -51.0% |
| 2022 | 0.98x | CN¥153.72 Million | CN¥110.43 Million | CN¥157.10 Million | ▼ -49.4% |
| 2021 | 1.93x | CN¥229.21 Million | CN¥183.30 Million | CN¥118.54 Million | ▼ -28.5% |
| 2020 | 2.70x | CN¥381.57 Million | CN¥263.73 Million | CN¥141.13 Million | ▼ -10.2% |
| 2019 | 3.01x | CN¥283.94 Million | CN¥172.52 Million | CN¥94.26 Million | ▲ +79.3% |
| 2018 | 1.68x | CN¥344.52 Million | CN¥146.52 Million | CN¥205.07 Million | ▼ -9.8% |
| 2017 | 1.86x | CN¥249.47 Million | CN¥108.21 Million | CN¥133.91 Million | ▼ -38.6% |
| 2016 | 3.03x | CN¥359.89 Million | CN¥212.89 Million | CN¥118.63 Million | ▼ -6.4% |
| 2015 | 3.24x | CN¥201.01 Million | CN¥169.36 Million | CN¥62.00 Million | ▲ +4.1% |
| 2014 | 3.11x | CN¥223.27 Million | CN¥214.23 Million | CN¥71.71 Million | ▼ -31.9% |
| 2013 | 4.57x | CN¥216.25 Million | CN¥196.82 Million | CN¥47.33 Million | ▼ -30.9% |
| 2012 | 6.62x | CN¥232.69 Million | CN¥151.93 Million | CN¥35.18 Million | ▲ +105.3% |
| 2011 | 3.22x | CN¥104.36 Million | CN¥77.06 Million | CN¥32.39 Million | — |